|
REGN7508 Clinical Trials
5 actively recruiting trials across 3 locations
▲ +1 trial since August 2026
Also known as: cenvacibart
Pipeline
Phase 2: 1Phase 3: 4
Top Sponsors
- Regeneron Pharmaceuticals5
Indications
- Atrial Fibrillation (AF)3
- Heart Disease3
- Lung Cancer2
- Cancer2
- Cancer-Associated Thrombosis (CAT)1
Dothan, Alabama2 trials
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
SEC Clinical Research
Phase 2
Hialeah, Florida2 trials
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Bioresearch Partner- Hialeah Hospital
Phase 3
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Bioresearch Partner- Hialeah Hospital
Phase 3
Alexander City, Alabama1 trial
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Advanced Cardiovascular
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.